✦ LIBER ✦

Lenalidomide in Myelodysplastic Syndromes: An Erythropoiesis-Stimulating Agent or More?

✍ Scribed by Rami S. Komrokji; Jeffrey E. Lancet; Alan F. List

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lenalidomide in lower-risk myelodysplast

✍ David Sibon; Giovanna Cannas; Fiorenza Baracco; Thomas Prebet; Norbert Vey; Anne 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Erythropoiesis-stimulating agents are ef

✍ David P. Steensma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Erythropoiesis-stimulating agents in the

✍ Victor Moyo; Patrick Lefebvre; Mei Sheng Duh; Behin Yektashenas; Suneel Mundle 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 209 KB

An assessment of erythroid response to e

✍ Suneel Mundle; Patrick Lefebvre; Francis Vekeman; Mei Scheng Duh; Ruchi Rastogi; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB